PubChem Substance and Compound databases
By Sunghwan Kim, Paul A. Thiessen, Evan E. Bolton, Jie Chen, Gang Fu, Asta Gindulyte, Lianyi Han, Jane He, Siqian He, Benjamin A. Shoemaker and 4 more. 2015
4,892 citations recorded by the source corpus.
PubChem (https://pubchem.ncbi.nlm.nih.gov) is a public repository for information on chemical substances and their biological activities, launched in 2004 as a component of the Molecular Libraries Roadmap Initiatives of the US National Institutes of Health (NIH). For the past 11 years, PubChem has grown to a sizable system, serving as a chemical information resource for the scientific research community. PubChem consists of three inter-linked databases, Substance, Compound and BioAssay. The Substance database contains chemical information deposited by individual data contributors to PubChem, and the Compound database stores unique chemical structures extracted from the Substance database. Biological activity data of chemical substances tested in assay experiments are contained in the BioAssay database. This paper provides an overview of the PubChem Substance and Compound databases, including data sources and contents, data organization, data submission using PubChem Upload, chemical structure standardization, web-based interfaces for textual and non-textual searches, and programmatic access. It also gives a brief description of PubChem3D, a resource derived from theoretical three-dimensional structures of compounds in PubChem, as well as PubChemRDF, Resource Description Framework (RDF)-formatted PubChem data for data sharing, analysis and integration with information contained in other databases.
Subfields: Computational Theory and Mathematics, Molecular Biology, ML Systems & Hardware, Computational Chemistry & Drug Discovery
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
- Evan E. Bolton
- Stephen H. Bryant
- Sunghwan Kim
- Charles Siegel
- Abhinav Vishnu
- Garrett B. Goh
- Nathan Oken Hodas
- Oliver Fiehn
In Molecular Biology
- David S. Wishart
- Stephen H. Bryant
- Jianguo Xia
- Evan E. Bolton
- Oliver Fiehn
- Jasmine Chong
- Anna R. Panchenko
- Benjamin A. Shoemaker
In ML Systems & Hardware
In Computational Chemistry & Drug Discovery
- F. Silva-Jr
- Paula Jofily
- R. Greiner
- Charles Siegel
- Abhinav Vishnu
- Evan E. Bolton
- Valery Tkachenko
- David Ryan Koes
Citations in the corpus
- Using Rule-Based Labels for Weak Supervised Learning: A ChemNet for Transferable Chemical Property Prediction (2017, background): “While sizable chemical databases like PubChem [21] and ChEMBL [11] do exist, their labels are skewed towards biomedical data, and such databases are only sparsely labelled, where each labeled data (i.e. measurements) are only available for a small subset (typically under 10”
- Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules (2016, neutral): “Making and testing new compounds are costly and time-consuming, and the number of potential candidates is overwhelming.”
- WILDS: A Benchmark of in-the-Wild Distribution Shifts (2020, neutral): “Some recent works have tried to balance this tradeoff between viewing overall context and the fine-grained detail (Uzkent and Ermon, 2020; Kim et al., 2016), but how best to do this is an open question.”
- Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases (2018, background): “Several data sets coming from PubChem, Tox21, MUV and DUDE were combined to achieve 38 million data points.”
- ChemNet: A Transferable and Generalizable Deep Neural Network for Small-Molecule Property Prediction (2017, background): “Sizable chemical databases like PubChem [14] and ChEMBL [15] do exist, but their labels are more focused towards biomedical data, and missing labels are a common occurrence.”
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules (2017, positive): “For CYP major isoforms, all datasets were those of Veith et al. 50 and downloaded from the PubChem database 72 (http://pubchem.ncbi.nlm.nih.gov, accessed February 2016).”
- Database resources of the National Center for Biotechnology Information (2017, background): “PubChem (9,10) is a resource that provides information on various chemical entities, including small molecules, siRNAs, miRNAs, carbohydrates, lipids, peptides, chemically modified macromolecules, and many others.”
- DeepDock: Enhancing Ligand-protein Interaction Prediction by a Combination of Ligand and Structure Information (2019, background): “[26] S. G. Rohrer, and K. Baumann, “Maximum unbiased validation (MUV) data sets for virtual screening based on PubChem bioactivity data,” Journal of chemical information and modeling, vol. 49, pp. 169–184, 2009.”
- Comparison of Deep Learning With Multiple Machine Learning Methods and Metrics Using Diverse Drug Discovery Data Sets. (2017, methodology): “The 4-fold stratified crossvalidation grid search using weighted classes was done for 2 kernels (linear, rbf), C (1, 10, 100), and gamma values (1e−2, 1e−3, 1e−4).”
- The rise of deep learning in drug discovery. (2018, background): “Over the past decade, there has been a remarkable increase in the amount of available compound activity and biomedical data [6,7] owing to the emergence of new experimental techniques such as HTS, parallel synthesis, among others [7,8].”